Beyond regulatory delays: How patent misuse impacts access to affordable medications
This Globe and Mail op-ed calls attention to how brand-name manufacturers are using the patent system to block affordable biosimilars and generics in Canada.
Tag #Patientsandpatents
How pharmaceutical patents make drugs expensive
In this video, science communicator Patrick Kelly uses engaging visuals and storytelling to explain the pharmaceutical patent system.
The unspoken cost of pharma IP protections from trade agreements
This infographic illustrates how trade agreements can increase drug prices by embedding extended intellectual property protections.
Why are drug prices so high?
This TED Talk by Priti Krishtel expresses how lack of transparency and misuse of patent protections are key contributions to skyrocketing drug costs.
Market access barriers
This report outlines key barriers that prevent biosimilar and generic medicines from reaching patients even after regulatory approval.
Do drugs get cheaper when their patents expire?
This video from STAT breaks down what happens to prescription drug prices after patents expire.